Skip to main content

Articles

Page 5 of 15

  1. Opioid overdose is a leading cause of death in persons experiencing homelessness (PEH), despite effective medications for opioid use disorder (OUD). In 2016, the San Francisco Street Medicine Team piloted a lo...

    Authors: Jamie Carter, Barry Zevin and Paula J. Lum
    Citation: Addiction Science & Clinical Practice 2019 14:20
  2. Primary care provider skills such as screening, longitudinal monitoring, and medication management are generalizable to prescribing alcohol use disorder (AUD) pharmacotherapy. The association between primary c...

    Authors: Paul J. Joudrey, Mat Kladney, Chinazo O. Cunningham and Marcus A. Bachhuber
    Citation: Addiction Science & Clinical Practice 2019 14:19
  3. Ontario patients on opioid agonist treatment (OAT) are often prescribed methadone instead of buprenorphine, despite the latter’s superior safety profile. Ontario OAT providers were surveyed to better understan...

    Authors: Anita Srivastava, Meldon Kahan, Pamela Leece and Alison McAndrew
    Citation: Addiction Science & Clinical Practice 2019 14:18
  4. Alcohol consumption among Indigenous Australians can be irregular, depending on social and geographic context. The Finnish method uses the last four drinking occasions to estimate drinking quantity and pattern...

    Authors: K. S. Kylie Lee, James H. Conigrave, Sarah Callinan, Scott Wilson, Robin Room, Jimmy Perry, Tim Slade, Tanya N. Chikritzhs, Noel Hayman, Teagan Weatherall, Geoffrey Leggat, Dennis Gray and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2019 14:15
  5. Post-release opioid-related overdose mortality is the leading cause of death among people released from jails or prisons (PRJP). Informed by the proximate determinants framework, this paper presents the Post-R...

    Authors: Paul J. Joudrey, Maria R. Khan, Emily A. Wang, Joy D. Scheidell, E. Jennifer Edelman, D. Keith McInnes and Aaron D. Fox
    Citation: Addiction Science & Clinical Practice 2019 14:17
  6. Alcohol use in HIV infected patients is associated with risky sexual behaviour, poor adherence to Highly Active Antiretroviral Therapy, treatment failure and increased physiologic harm. The objectives of the s...

    Authors: Munyaradzi Madhombiro, Bazondlile Dube, Michelle Dube, Moleen Zunza, Dixon Chibanda, Simbarashe Rusakaniko and Soraya Seedat
    Citation: Addiction Science & Clinical Practice 2019 14:16
  7. Women recently released from incarceration have increased rates of co-occurring substance use, physical health, and mental health disorders. During re-entry, they face challenges navigating needed health servi...

    Authors: Katherine Thomas, John L. Wilson, Precious Bedell and Diane S. Morse
    Citation: Addiction Science & Clinical Practice 2019 14:12
  8. Tobacco use and heavy episodic drinking (HED) commonly co-occur in young adults. We developed and tested usability of the Smoking Tobacco and Drinking (STAND) intervention for young adults delivered on Facebook.

    Authors: Danielle E. Ramo, Meredith C. Meacham, Manpreet Kaur, Ella S. Corpuz, Judith J. Prochaska and Derek D. Satre
    Citation: Addiction Science & Clinical Practice 2019 14:14
  9. A substantial increase in substance treatment episodes for methamphetamine problems suggests characteristics of the treatment population could have changed and that targeted treatment programs are required. To...

    Authors: Julaine Allan, Ryan H. L. Ip, Michael Kemp and Nicole Snowdon
    Citation: Addiction Science & Clinical Practice 2019 14:13
  10. Buprenorphine effectively reduces opioid craving and illicit opioid use. However, some patients may not take their medication as prescribed and thus experience suboptimal outcomes. The study aim was to qualita...

    Authors: Margo E. Godersky, Andrew J. Saxon, Joseph O. Merrill, Jeffrey H. Samet, Jane M. Simoni and Judith I. Tsui
    Citation: Addiction Science & Clinical Practice 2019 14:11
  11. Swedish national guidelines recommend that all health care settings systematically screen patients for alcohol use and illicit substance use. When hazardous use is identified, it should immediately be addresse...

    Authors: Christopher Sundström, Elisabeth Petersén, Kristina Sinadinovic, Peter Gustafsson and Anne H. Berman
    Citation: Addiction Science & Clinical Practice 2019 14:10
  12. Women experiencing incarceration (WEI) engage in high rates of sex- and drug-related behavior that places them at risk for HIV. Pre-exposure prophylaxis (PrEP) is an efficacious means of reducing HIV acquisiti...

    Authors: Susan E. Ramsey, Evan G. Ames, Lauren Brinkley-Rubinstein, Anne M. Teitelman, Jennifer Clarke and Clair Kaplan
    Citation: Addiction Science & Clinical Practice 2019 14:8
  13. More than 80% of people in jail or prison report having used illicit substances in their lifetimes. After release from incarceration, resumption of substance use carries risks, including parole revocation, exa...

    Authors: Adam Chamberlain, Sylviah Nyamu, Jenerius Aminawung, Emily A. Wang, Shira Shavit and Aaron D. Fox
    Citation: Addiction Science & Clinical Practice 2019 14:7
  14. Treatment for opioid use disorder (OUD) is highly effective, yet it remains dramatically underutilized. Individuals with OUD have disproportionately high rates of hospitalization and low rates of addiction tre...

    Authors: Jennifer McNeely, Andrea B. Troxel, Hillary V. Kunins, Donna Shelley, Joshua D. Lee, Alexander Walley, Zoe M. Weinstein, John Billings, Nichola J. Davis, Roopa Kalyanaraman Marcello, Bruce R. Schackman, Charles Barron and Luke Bergmann
    Citation: Addiction Science & Clinical Practice 2019 14:5
  15. Effective medications for treating alcohol use disorders (AUD) are available but underutilized. Multiple barriers to their provision have been identified, and optimal strategies for addressing and overcoming b...

    Authors: Emily C. Williams, Theresa E. Matson and Alex H. S. Harris
    Citation: Addiction Science & Clinical Practice 2019 14:6
  16. Residential opioid rehabilitation aims to improve the mental health and quality of life of opioid users through abstinence and residential program participation. This study aimed to determine the depression, a...

    Authors: Madeleine M. Southey, Trent Rees, Margaret Rolfe and Sabrina Pit
    Citation: Addiction Science & Clinical Practice 2019 14:4
  17. In Dar es Salaam Tanzania, the first opioid treatment program (OTP) in Sub-Saharan Africa, had very high rates of enrollment of people who use drugs (PWUD) but low rates of antiretroviral therapy (ART) initiat...

    Authors: Alexis Cooke, Haneefa Saleem, Saria Hassan, Dorothy Mushi, Jessie Mbwambo and Barrot Lambdin
    Citation: Addiction Science & Clinical Practice 2019 14:3
  18. Tobacco use remains the leading cause of preventable disease and death in the United States and is concentrated among disadvantaged populations, including individuals with a history of criminal justice involve...

    Authors: Tyler N. A. Winkelman, Katherine Diaz Vickery and Andrew M. Busch
    Citation: Addiction Science & Clinical Practice 2019 14:2
  19. Alcohol use disorder (AUD) and unhealthy drinking are prevalent among women involved in the criminal justice system and women military veterans. Pharmacotherapy—including naltrexone, topiramate, acamprosate, a...

    Authors: Emmeline Taylor, Christine Timko, Alex H. S. Harris, Mengfei Yu and Andrea K. Finlay
    Citation: Addiction Science & Clinical Practice 2019 14:1
  20. Alarming rates of unhealthy alcohol, non-prescription drug, and tobacco use highlight the preventable health risks of substance abuse and the urgent need to activate clinicians to recognize and treat risky use...

    Authors: Robin Newhouse, Michelle Janney, Anne Gilbert, Jon Agley, Giorgos Bakoyannis, Melora Ferren, C. Daniel Mullins, Meg Johantgen, Rhonda Schwindt and Kelli Thoele
    Citation: Addiction Science & Clinical Practice 2018 13:28
  21. Medically complex urban patients experiencing homelessness comprise a disproportionate number of high-cost, high-need patients. There are few studies of interventions to improve care for these populations; the...

    Authors: Brian Chan, Samuel T. Edwards, Meg Devoe, Richard Gil, Matthew Mitchell, Honora Englander, Christina Nicolaidis, Devan Kansagara, Somnath Saha and P. Todd Korthuis
    Citation: Addiction Science & Clinical Practice 2018 13:27
  22. In the US, emergency room visits and overdoses related to prescription opioids have soared and the rates of illicit opioid use, including heroin and fentanyl, are increasing. Opioid use disorder (OUD) is assoc...

    Authors: Hildi Hagedorn, Marie Kenny, Adam J. Gordon, Princess E. Ackland, Siamak Noorbaloochi, Wei Yu and Alex H. S. Harris
    Citation: Addiction Science & Clinical Practice 2018 13:25
  23. Patients with alcohol misuse are less likely to receive preventive health services but more likely to utilize emergency health services. However, the association between alcohol misuse and outpatient follow-up...

    Authors: Bryan Borg, Ivor S. Douglas, Madelyne Hull, Angela Keniston, Marc Moss and Brendan J. Clark
    Citation: Addiction Science & Clinical Practice 2018 13:24
  24. The non-medical use of opioids has reached epidemic levels nationwide, and rural areas have been particularly affected by increasing rates of overdose mortality as well as increases in the prison population. I...

    Authors: Amanda M. Bunting, Carrie B. Oser, Michele Staton, Katherine S. Eddens and Hannah Knudsen
    Citation: Addiction Science & Clinical Practice 2018 13:23
  25. Drug overdose deaths involving opioids have surged in recent years and the economic cost of the opioid epidemic is estimated to be over $500 billion annually. In the midst of calls for declaring a national eme...

    Authors: Matthew A. Miclette, Jared A. Leff, Isabella Cuan, Jeffrey H. Samet, Brendan Saloner, Gary Mendell, Yuhua Bao, Michael A. Ashburn, Marcus A. Bachhuber, Bruce R. Schackman, Daniel E. Polsky and Zachary F. Meisel
    Citation: Addiction Science & Clinical Practice 2018 13:22
  26. While buprenorphine/naloxone (B/N) is approved for opioid use disorder treatment, effective delivery of B/N comes with significant challenges. Most notably, many patients do not take medication daily as prescr...

    Authors: Zev Schuman-Olivier, Jacob T. Borodovsky, Jackson Steinkamp, Qays Munir, Kyle Butler, Mary Ann Greene, Jonah Goldblatt, Hai Yi Xie and Lisa A. Marsch
    Citation: Addiction Science & Clinical Practice 2018 13:21
  27. Addiction treatment improves substance use and criminal recidivism outcomes among justice-involved individuals with substance use disorders, but is underutilized. Although information exists regarding barriers...

    Authors: Mandy D. Owens, Jessica A. Chen, Tracy L. Simpson, Christine Timko and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2018 13:19
  28. The emergency department (ED) has long been recognized as providing critical access to the health care system for many, yet only in the past few decades has the ED visit been recognized as an opportunity to id...

    Authors: Kathryn Hawk and Gail D’Onofrio
    Citation: Addiction Science & Clinical Practice 2018 13:18

    The Correction to this article has been published in Addiction Science & Clinical Practice 2019 14:26

  29. Increasing understanding of the pathways and processes of recovery from cannabis use disorder may help in designing effective and attractive interventions to promote recovery. We report insights from individua...

    Authors: David C. Hodgins and Jonathan N. Stea
    Citation: Addiction Science & Clinical Practice 2018 13:16
  30. Little is known about tobacco smoking behaviors of healthcare professionals in the Middle East where stress conditions are high and tobacco smoking regulations are either absent or loose. The objective of this...

    Authors: Isra Y. Mizher, Shahd I. Fawaqa and Waleed M. Sweileh
    Citation: Addiction Science & Clinical Practice 2018 13:17
  31. Opioid-related overdose deaths have risen sharply among young adults. Despite this increase, access to evidence-based medication for opioid agonist treatment (OAT) for youth remains low. Among older adults, ba...

    Authors: Scott E. Hadland, Tae Woo Park and Sarah M. Bagley
    Citation: Addiction Science & Clinical Practice 2018 13:15
  32. For over a decade, the vast majority of new hepatitis C virus (HCV) infections have been among young people who inject drugs (PWID). Well-characterized gaps in chronic HCV diagnosis, evaluation, and treatment ...

    Authors: Stephen A. Martin, Jordon Bosse, Amanda Wilson, Phyllis Losikoff and Lisa Chiodo
    Citation: Addiction Science & Clinical Practice 2018 13:10
  33. Contemporary advances in addiction neuroscience have paralleled increasing interest in the ancient mental training practice of mindfulness meditation as a potential therapy for addiction. In the past decade, ...

    Authors: Eric L. Garland and Matthew O. Howard
    Citation: Addiction Science & Clinical Practice 2018 13:14
  34. Alcohol and drug use are leading causes of morbidity and mortality that frequently go unidentified in medical settings. As part of a multi-phase study to implement electronic health record-integrated substanc...

    Authors: Jennifer McNeely, Pritika C. Kumar, Traci Rieckmann, Erica Sedlander, Sarah Farkas, Christine Chollak, Joseph L. Kannry, Aida Vega, Eva A. Waite, Lauren A. Peccoralo, Richard N. Rosenthal, Dennis McCarty and John Rotrosen
    Citation: Addiction Science & Clinical Practice 2018 13:8
  35. HIV-infected people who use drugs (PWUD) exhibit the highest rates of non-adherence to antiretroviral therapy (ART) among people living with HIV. This contributes to poor treatment outcomes, increased morbidit...

    Authors: Kasey Claborn, Sara Becker, Don Operario, Steve Safren, Josiah D. Rich and Susan Ramsey
    Citation: Addiction Science & Clinical Practice 2018 13:12
  36. Aboriginal and Torres Strait Islander Community Controlled Health Services (ACCHSs) around Australia have been asked to standardise screening for unhealthy drinking. Accordingly, screening with the 3-item AUD...

    Authors: M. Mofizul Islam, Helen T. Oni, K. S. Kylie Lee, Noel Hayman, Scott Wilson, Kristie Harrison, Beth Hummerston, Rowena Ivers and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2018 13:5
  37. Research has identified drinking motives as the final common pathway to alcohol use, and associations between specific drinking motives and drinking patterns have consistently been demonstrated. Data on drinki...

    Authors: Christina Nehlin, Margareta Wennberg and Caisa Öster
    Citation: Addiction Science & Clinical Practice 2018 13:7
  38. While brief intervention (BI) for risky alcohol use generally yields positive effects among those identified by screening, effect sizes are small and there is unexplained heterogeneity in outcome. The heterog...

    Authors: Jennifer E. Hettema, Stephanie A. Cockrell, Abigail Reeves, Karen S. Ingersoll, Paula J. Lum, Richard Saitz, Cristina M. Murray-Krezan and Valerie A. Carrejo
    Citation: Addiction Science & Clinical Practice 2018 13:6
  39. Upon publication of the original article

    Authors: Bryan R. Garner, Heather J. Gotham, Stephen J. Tueller, Elizabeth L. Ball, David Kaiser, Patricia Stilen, Kathryn Speck, Denna Vandersloot, Traci R. Rieckmann, Michael Chaple, Erika G. Martin and Steve Martino
    Citation: Addiction Science & Clinical Practice 2018 13:9

    The original article was published in Addiction Science & Clinical Practice 2017 12:31

  40. A growing body of evidence supports the effectiveness of injectable diacetylmorphine (i.e., heroin) for individuals with treatment-refractory opioid use disorder. Despite this evidence, and the increasing toll...

    Authors: Jan Klimas, Huiru Dong, Nadia Fairbairn, Eugenia Socías, Rolando Barrios, Evan Wood, Thomas Kerr, Julio Montaner and M.-J. Milloy
    Citation: Addiction Science & Clinical Practice 2018 13:3
  41. Increasing alcohol use is associated with increased risk of mortality among patients living with HIV (PLWH). This association varies by race/ethnicity among general outpatients, but racial/ethnic variation ha...

    Authors: Kara M. Bensley, Kathleen A. McGinnis, David A. Fiellin, Adam J. Gordon, Kevin L. Kraemer, Kendall J. Bryant, E. Jennifer Edelman, Stephen Crystal, Julie R. Gaither, P. Todd Korthuis, Brandon D. L. Marshall, India J. Ornelas, K. C. Gary Chan, Julia C. Dombrowski, John C. Fortney, Amy C. Justice…
    Citation: Addiction Science & Clinical Practice 2018 13:2
  42. Methamphetamine (MA) is a highly addictive psychostimulant used by approximately 52 million people worldwide. Chronic MA abuse leads to detrimental physiological and neurological changes, as well as increases ...

    Authors: Linzette Morris, Jessica Stander, Wardah Ebrahim, Stephanie Eksteen, Orissa Anna Meaden, Ané Ras and Annemarie Wessels
    Citation: Addiction Science & Clinical Practice 2018 13:4
  43. Few studies describe medical complaints and substance use patterns related to attending music concerts. As such, the objective of this study is to describe patient demographics, substance use and intoxication ...

    Authors: Stephanie M. Ruest, Alexander M. Stephan, Peter T. Masiakos, Paul D. Biddinger, Carlos A. Camargo and Sigmund Kharasch
    Citation: Addiction Science & Clinical Practice 2018 13:1
  44. Over 1.6 million adolescents in the United States meet criteria for substance use disorders (SUDs). While there are promising treatments for SUDs, adolescents respond to these treatments differentially in part...

    Authors: Sean Grant, Denis Agniel, Daniel Almirall, Q. Burkhart, Sarah B. Hunter, Daniel F. McCaffrey, Eric R. Pedersen, Rajeev Ramchand and Beth Ann Griffin
    Citation: Addiction Science & Clinical Practice 2017 12:35
  45. Substance use is common among people living with HIV (PLHIV) and is associated with worse outcomes along the HIV care continuum. One potentially effective clinic-based approach to addressing unhealthy substanc...

    Authors: Carol Dawson-Rose, Jessica E. Draughon, Yvette Cuca, Roland Zepf, Emily Huang, Bruce A. Cooper and Paula J. Lum
    Citation: Addiction Science & Clinical Practice 2017 12:34

Affiliated with

Annual Journal Metrics

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.